Botanical species · safety record

Strophanthus hispidus

The EFSA Compendium of Botanicals holds 14 constituent measurements for Strophanthus hispidus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Strophanthus hispidus DC.

14Constituent measurements
0Safety records
5Cited sources
16Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 16 licensed products naming Strophanthus hispidus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Seed(s)

What the records describe

Constituents measured

  • Cardiac glycosides3
  • Alkaloids2
  • Anthraquinones2
  • Tannins2
  • Cardenolide glycosides1
  • Cyanogenic glycosides1
  • Cymarin1
  • K-strophanthidin1
  • Saponins1

Plant parts

  • Roots and other underground parts7
  • Leaves4
  • Seed3

Preparations

  • Solvent extraction14

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsRoots and other underground partsSolvent extractionPhytochemical screeningResolve DOI
AlkaloidsLeavesSolvent extractionPhytochemical screeningResolve DOI
AnthraquinonesRoots and other underground partsSolvent extractionPhytochemical screeningResolve DOI
Cardenolide glycosidesSeedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Cardiac glycosidesRoots and other underground partsSolvent extractionPhytochemical screeningResolve DOI
Cardiac glycosidesLeavesSolvent extractionPhytochemical screeningResolve DOI
Cyanogenic glycosidesLeavesSolvent extractionPhytochemical screeningResolve DOI
SaponinsLeavesSolvent extractionPhytochemical screeningResolve DOI
TanninsRoots and other underground partsSolvent extractionPhytochemical screeningResolve DOI
AnthraquinonesRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
Cardiac glycosidesRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
CymarinSeedSolvent extractionTraditional analytical techniques (wet chemical tests)No resolvable identifier
K-strophanthidinSeedSolvent extractionTraditional analytical techniques (wet chemical tests)No resolvable identifier
TanninsRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Oluwatoyin, A., Samuel, F.M. Anti-nociceptive activity of fractionated root extract of strophanthus hispidus DC (Apocynaceae). Journal of natural remedies, 2014, vol. 14, no. 2, p. 164-173. DOI
  2. Ojiako, O.A., Igwe, C.U. A time-trend hypoglycemic study of ethanol and chloroform extracts of strophanthus hispidus. Journal of herbs, spices and medicinal plants, 2009, vol. 15, no. 1, p. 1-8. DOI
  3. Jacobs, Walter A., Hoffmann, Alexander. Strophanthin. XV. Hispidus strophanthin. Journal of biological chemistry, 1928, vol. 79, p. 531-7.
  4. Agbaje, E.O., Fageyinbo, M.S. Evaluating anti-Inflammatory activity of aqueous root extract of Strophanthus hispidus DC. (Apocynaceae). International journal of applied research in natural products, 2011, vol. 4, no. 4, p. 7-14.
  5. KARTNIG, T., DANHOFER, R. A METHOD FOR IDENTIFICATION AND QUANTITATIVE ANALYSIS OF STROPHANTHUS GLYCOSIDES . Journal of chromatography, 1970, vol. 52, no. 2, p. 313-&. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue